Lv21
108 积分 2023-01-10 加入
Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
4小时前
待确认
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non–Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART)
9小时前
已完结
High-dose biologics and bioconjugates delivery: Integrating molecular optimization with device design and routes of administration
11天前
已完结
Subcutaneous rituximab in indolent primary cutaneous B-cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact
21天前
已关闭
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
21天前
已完结
Reversing Transplant Ineligibility With Teclistamab in Ultra–High-Risk Relapsed/Refractory Multiple Myeloma With Extramedullary Disease
21天前
已完结
Subcutaneous rituximab in indolent primary cutaneous B-cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact
21天前
已关闭
Cytomegalovirus reactivation with severe lymphopenia during elranatamab treatment: a case series in patients with triple-class refractory multiple myeloma
21天前
已完结
Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event
21天前
已完结
Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency?
29天前
已完结
皖公网安备34019202002308
